flu4

The Study:

  • This study evaluates the immune response of both healthy adults 50 years of age and older and healthy adults 18 years of age and older. The purpose of this study is to investigate the safety and immunogenicity of GSK’s Shingles and Flu vaccines when administered sequentially or simultaneously with Moderna’s mRNA-1273 booster against COVID-19. Current CDC guidance on the coadministration of COVID-19 vaccines with other routine vaccinations is as follows: “COVID-19 vaccines and other vaccines may now be administered without regard to timing. This includes simultaneous administration of COVID-19 vaccine and other vaccines on the same day, as well as coadministration within 14 days (about 2 weeks)” [CDC, 2021c]. This is important needed data expected to help public health authorities provide more evidence-based guidance and health care providers to make decisions on such vaccine coadministrations.

 

Qualified Participants:

  • Be a healthy adult 18 and older to receive the influenza vaccine with the COVID-19 booster; or be a healthy adult 50 and older to receive the shingles vaccine with the COVID-19 booster.
  • Have received both dosses of the Moderna COVID-19 vaccine at least 6 months prior to first vaccination in this study.

 

If Qualified and you participate you will receive:

  • All study-related medical exams, lab tests, investigational medication or placebo at no cost.
  • Compensation for time and travel.
  • Insurance is not required.

If you are interested in participating in this study, please fill out the form to the right. This will help us determine if you meet some of the initial criteria necessary to participate. We will contact you within 48 hours (about 2 days) to follow-up and clarify any questions that you, or we, may have. The information you provide is entered into our secure, password protected database which can only be accessed by authorized AMR Norfolk personnel, unless given your permission or except as required by law. Provided information will only be used to contact you to tell you more about this and any future study. Your contact information will remain within our database indefinitely unless otherwise requested.

Take the next step, call us at (757) 627-6798 and ask for the Asthma enrollment team, better yet, fill out the brief contact form, and we will call you!

×

Make an appointment and we’ll contact you.